泓博医药 (301230.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(泓博医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 129,557,463.40116,262,612.73121,392,447.24146,754,883.28126,261,736.06101,552,674.02104,314,490.66
 营业收入(元) 129,557,463.40116,262,612.73121,392,447.24146,754,883.28126,261,736.06101,552,674.02104,314,490.66
二、营业总成本(元) 119,059,485.9095,824,070.44104,504,260.72118,668,916.80108,584,166.3189,693,558.6492,457,818.09
 营业成本(元) 90,782,542.8071,419,285.6977,917,655.6590,177,555.9484,044,363.2661,575,381.1366,503,934.73
 研发费用(元) 9,434,861.999,120,578.5410,163,571.9210,206,604.308,476,194.705,994,840.267,974,960.23
 营业税金及附加(元) 360,029.31242,658.06312,473.12410,807.74476,639.52365,880.22408,405.80
 销售费用(元) 3,365,758.372,959,383.662,563,164.873,095,750.552,323,475.841,177,186.461,522,497.10
 管理费用(元) 15,067,377.3415,507,634.9613,311,726.4915,105,928.7716,205,716.6826,435,197.3814,300,175.62
 财务费用(元) 48,916.09-3,425,470.47235,668.67-327,730.50-2,942,223.69-5,854,926.811,747,844.61
  其中:利息费用(元) 910,206.72984,947.551,045,393.661,150,453.601,190,888.311,187,798.841,263,568.72
  其中:利息收入(元) 644,680.10460,357.863,058,391.182,449,112.55239,021.78121,633.4274,050.65
 资产减值损失(元) -397,259.67-644,106.46-1,365,671.84-563,463.90492,854.42-531,476.72-1,561,574.54
 信用减值损失(元) -1,157,254.41939,024.7466,893.06-70,357.10154,283.85-444,895.38613,628.69
三、其他经营收益
 加:公允价值变动收益(元) 5,343,398.76-3,887,612.99901,397.8061,109.8686,293.90148,889.26-395,647.75
 加:投资收益(元) -2,289,148.992,554,073.69461,082.243,708.00128,166.1017,197.14454,252.67
  其中:对联营企业和合营企业的投资收益(元) -----1,329.34-597.33
 资产处置收益(元) 2,779.05-3,020.49----
 其他收益(元) 723,159.103,260.00413,168.873,309,794.80205,917.10582,642.00674,632.10
四、营业利润(元) 12,723,651.3419,403,181.2717,368,077.1430,826,758.1418,745,085.1211,631,471.6811,641,963.74
 加:营业外收入(元) 0.20600.006,150.02-124,786.675,050.0075,833.00
 减:营业外支出(元) 222,438.07142,560.97137,019.6055,547.0019,558.6738,080.1016,239.59
五、利润总额(元) 12,501,213.4719,261,220.3017,237,207.5630,771,211.1418,850,313.1211,598,441.5811,701,557.15
 减:所得税费用(元) -544,611.491,648,823.891,961,411.211,768,610.411,198,451.061,466,673.061,311,906.01
六、净利润(元) 13,045,824.9617,612,396.4115,275,796.3529,002,600.7317,651,862.0610,131,768.5210,389,651.14
(一)按经营持续性分类
  持续经营净利润(元) 13,045,824.9617,612,396.4115,275,796.3529,002,600.7317,651,862.0610,131,768.5210,389,651.14
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 13,045,824.9617,612,396.4115,275,796.3529,002,600.7317,651,862.0610,131,768.5210,389,651.14
 扣除非经常性损益后的净利润(元) 9,296,829.9219,389,712.3313,739,956.8326,171,967.4417,191,800.009,502,100.009,774,500.00
七、每股收益
 一、基本每股收益(元) 0.120.110.200.440.300.180.18
 二、稀释每股收益(元) 0.120.110.200.440.300.180.18
八、其他综合收益(元) -12,550.60-82,460.86-50,245.36-11,571.67-19,310.5750,807.07
 归属于母公司股东的其他综合收益(元) -12,550.60-82,460.86-50,245.36-11,571.67-19,310.5750,807.07
九、综合收益总额(元) 13,033,274.3617,612,396.4115,358,257.2128,952,355.3717,640,290.3910,112,457.9510,440,458.21
 归属于母公司所有者的综合收益总额(元) 13,033,274.3617,612,396.4115,358,257.2128,952,355.3717,640,290.3910,112,457.9510,440,458.21
公告日期 2023-10-262023-08-292023-04-262023-04-222022-10-312022-09-302023-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院